Table 3 Clinical trials

From: Network integration of multi-tumour omics data suggests novel targeting strategies

Inhibition target

Number of clinical trials

Cluster signature

ALOX5

18

1, 3

CHUK

9

1

FYN

97

2

IL6R

2

2

NFKB1

40

1, 2

NKFB2

8

1

NKFBIA

8

1, 2

PARP1

106

2

PPP2CB

5

1

PSMB9

25

1

SRC

135

1, 2

  1. List of signature genes that are also being tested in ongoing clinical trials (according to AACT database)
Back to article page